54 results
8-K
EX-99.5
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
, as applicable, that review, approve and oversee basic and clinical research conducted as the institution participating in the clinical trial
8-K
EX-99.6
rjs503 6rmp1d9m
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
ezrehqawis 5h1iqn4
10 Nov 22
Prospectus supplement
4:21pm
425
kdnopmcz7ui
28 Jun 22
Business combination disclosure
4:03pm
8-K
EX-99.1
wbt741
28 Jun 22
Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief Scientific Officer
4:02pm
8-K
5ryoc4d0u7il1
28 Jun 22
Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief Scientific Officer
4:02pm